Table 1.
Patient characteristics for enummeration experiments.
| CKD1-5 | HD | PD | P-value | |
|---|---|---|---|---|
| Number | 175 | 7 | 11 | |
| Age (y) | 63.3 (26.6) | 68.0 (24.0) | 50.0 (21.0) | NS |
| Gender (M/F) | 116/59 | 3/4 | 9/2 | NS |
| BMI (kg/m²) | 27.9 (7.1) | 22.6 (15.5) | 26.0 (3.3) | NS |
| Diabetes (%) | 34.3 | 40.0 | 33.3 | NS |
| Creatinine (mg/dL) | 1.4 (0.7) | 8.1 (3.2) | 6.6 (3.9) | 0.0001 |
| Urea (mg/dL) | 0.52 (0.45) | na | 1.21 (0.13) | 0.005 |
| Serum protein content (g/L) | 70.1 ± 0.5 | 65.0 ± 8.0 | 59.0 ± 4.9 | 0.032 |
| Total cholesterol (mg/dL) | 180.3 (54.2) | 159.0 (48.0) | 170.0 (56.7) | NS |
| HDL cholesterol (mg/dL) | 50.9 (21.0) | 46.0 (5.0) | 52.5 (25.4) | NS |
| Fasting triglycerides (mg/dL) | 127.2 (78.3) | 134.0 (64.0) | 136.0 (64.6) | NS |
| CRP (mg/L) | 1.8 (3.2) | 9.0 (10.0) | 3.5 (9.6) | NS |
| WBC (/µl) | 7071 (2876) | 6813 (2857) | 6735 (2915) | NS |
| Monocytes (/µl) | 768 (379) | 948.8 (1270.5) | 640.5 (634.4) | NS |
| Ezetimibe (%) | 0.6 | na | na | |
| Fibrates (%) | 2.2 | na | na | |
| Statins (%) | 55.6 | na | na | |
| Aspirin (%) | 33.7 | na | na | |
| Other anti-aggregates (%) | 9 | na | na |
Abbreviations: CKD: Chronic kidney disease; HD: hemodialysis; PD: peritoneal dialysis; BMI: body mass index; CRP: C-reactive protein; WBC; White blood cells; na: not available; NS: not significant. Data are reported as mean ± SD or median (interquartile range).